Beyond cancer cell‐expressed AREG in special cases, the TME‐derived AREG exerts an extra layer of chronic and long‐term pathological impacts on patients, including but not limited to development of acquired resistance to anti‐EGFR therapies such as cetuximab. Here, EGFR is linked to cancer.